PMID: 2813662Jan 1, 1989

Adverse effects of clozapine

Psychopharmacology
R GrohmannL G Schmidt

Abstract

Adverse effects related to clozapine were assessed within a post-marketing drug surveillance program, the AMUP study, in two university psychiatric departments. In a randomly selected sample of patients (intensive drug monitoring) ADRs of any type were observed in 76% of clozapine-treated inpatients. Sedation, hypersalivation, increase in transaminases, and EEG changes were most frequently observed, but only rarely required changes in therapy. In 8.1% of 959 patients exposed to clozapine in the total inpatient population of the participating hospitals ADR led to withdrawal of clozapine; in 3.9% reactions judged as severe and potentially life-threatening occurred. Among these latter toxic delirium prevailed. In addition, four cases of severe cardiovascular and respiratory dysregulation were observed with the combination of clozapine and benzodiazepines. These cases and one case of sudden death under clozapine and haloperidol treatment are presented in some detail. The results obtained for clozapine are compared to data from this drug surveillance program for other neuroleptics.

References

Mar 11, 1977·European Journal of Clinical Pharmacology·J Idänpään-HeikkiläI P Palva
May 1, 1987·Comprehensive Psychiatry·L G SchmidtB Müller-Oerlinghausen
Mar 1, 1969·British Medical Journal·N Hurwitz, O L Wade
Jan 1, 1984·European Journal of Clinical Pharmacology·R GrohmannB Wolf
Jul 1, 1984·Acta Psychiatrica Scandinavica·L G SchmidtB Wolf
Aug 1, 1965·American Journal of Public Health and the Nation's Health·L G SEIDLL E CLUFF

Citations

May 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·D MarinkovicV R Paunovic
Mar 1, 1995·The Journal of Emergency Medicine·M R Welber, S Nevins
Mar 14, 1991·The New England Journal of Medicine·R J Baldessarini, F R Frankenburg
Jul 1, 1996·Psychophysiology·D E RossK S Kendler
Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·E GouzoulisU von Bardeleben
Feb 1, 1995·Archiv der Pharmazie·J F LiégeoisJ Pincemail
Mar 7, 2006·Clinical Neuropharmacology·Constantin TranulisDavid Gourion
Jul 26, 2005·Journal of Psychiatric Practice·Vijayalakshmy PatrickSteven Schleifer
Sep 28, 2005·CNS Drugs·Gary RemingtonChekkera Shammi
Jan 1, 2006·International Journal of Psychiatry in Clinical Practice·G B Gupta, M K Sahu
Oct 20, 1998·Journal of Toxicology. Clinical Toxicology·T J HarmonE Cortes-Belen
Mar 30, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C Stanniland, D Taylor
Sep 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jeffrey K Aronson, Robin E Ferner
Jan 2, 2016·The International Journal of Neuropsychopharmacology·M E FriedrichS Kasper
Feb 22, 2005·The Journal of Pharmacy and Pharmacology·Vincenzo CalderoneMaria Cristina Breschi
Dec 1, 1996·Biological Psychiatry·T RabinowitzJ Kando
Jan 1, 1996·The American Journal of Emergency Medicine·J KetchL Ludwig
Jan 1, 1995·International Journal of Psychiatry in Medicine·M Sajatovic, L Ramirez
Aug 4, 2001·The Annals of Pharmacotherapy·J D HoehnsK B Tu
Jul 22, 2009·Clinical Neuropharmacology·Fayçal MouaffakMarie-Odile Krebs
Aug 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·G StoppeE Rüther
Jun 1, 2000·Journal of Clinical Psychopharmacology·I ModaiM Ritsner
Aug 1, 1997·Therapeutic Drug Monitoring·H WeigmannC Hiemke
Dec 4, 2003·CNS Drug Reviews·Shiho HirotaShigeru Okuyama
May 1, 1997·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M Wilkins-Ho, Y Hollander
Sep 6, 2007·The Annals of Pharmacotherapy·Carolina Molina LoweAnn C Scates
Apr 1, 1994·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R A DicksonJ T Dalby
Jan 5, 2002·Journal of Clinical Psychopharmacology·H TieS N Breit
Jun 1, 1996·The Annals of Pharmacotherapy·R J LeoK Y Kim

Related Concepts

Leponex
Dibenzazepines
Drug Interactions
Psychoses, Drug
Schizophrenia

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here